Farrukh Awan, MBBS | Authors


Dr. Farrukh Awan on Clinical Activity of Entospletinib in Patients with CLL

December 07, 2015

Farrukh T. Awan, MBBS, discusses a phase II trial examining the clinical activity of entospletinib in patients with chronic lymphocytic leukemia who were previously treated with a B-cell receptor pathway signaling inhibitor.